Galectin Therapeutics Inc.
Galectin Therapeutics Inc. (GALT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GALT · as of Jun 8, 2026
Key Statistics
Explore Galectin Therapeutics Inc. Data
galt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 81.8%
The GALT analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $11.00, representing +358.33% upside from the current price of $2.40.
Competitors & Peers
galt competitorsGALT
ALT
AURA
DMAC
DRTS
DSGNStock Performance
Full HistoryAbout Galectin Therapeutics Inc.
Galectin Therapeutics Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing new therapies for a spectrum of illnesses, including fibrotic disord…
what is galectin therapeutics inc. · galt stock overview · galectin therapeutics inc. company profile · who is galectin therapeutics inc. ceo · galt NASDAQ · galectin therapeutics inc. headquarters · galectin therapeutics inc. business segments
About Stock Overview & Key Data
Galectin Therapeutics Inc. (GALT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 4, 2002. As of the latest trading session, GALT stock price is $2.40, with a market capitalization of $158.1M. The stock has returned +78.79% over the past 12 months and -43.27% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Galectin Therapeutics Inc. stock is Buy, with an average 12-month price target of $11.00. In fiscal year 2025, Galectin Therapeutics Inc. reported revenue of — and net income of -$30.8M. For detailed data — including Galectin Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Galectin Therapeutics Inc. (GALT) stock price is $2.40. The stock is traded on NASDAQ under the ticker symbol GALT. The 52-week range is $1.27 – $7.13.